SCHEMBL880512

SCHEMBL880512

C1CCCC(N2C3COCC2COC3)CCC1

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 1/20 0.39
OGFRL1 Q5TC84 2/20 0.35
OPRM1 P35372 1/20 0.35
OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13243088 0.92 MEN1 (0.42) MEN1KMT2ACYP2D6OGFRL1OPRM1
SCHEMBL853501 0.80 MAPK1 (0.45) MEN1KMT2ACYP2D6OGFRL1OPRM1
SCHEMBL21547917 0.78 KMT2A (0.41) MEN1KMT2ACYP2D6OPRM1OPRK1
SCHEMBL10269953 0.78 KMT2A (0.46) MEN1KMT2ACYP2D6OPRM1OPRK1
SCHEMBL12028780 0.76 KMT2A (0.45) MEN1KMT2ACYP2D6OPRM1OPRK1
SCHEMBL12345490 0.76 KMT2A (0.45) MEN1KMT2ACYP2D6OPRM1OPRK1
SCHEMBL880757 0.76 KMT2A (0.45) MEN1KMT2ACYP2D6OPRM1OPRK1
SCHEMBL23315939 0.74 PHGDH (0.45) MEN1KMT2A
SCHEMBL17661306 0.69
SCHEMBL20641844 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433937-A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof Purdue Pharma LP (US) 2012-03-28 EP disclosed
EP-2433935-A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof Purdue Pharma LP (US) 2012-03-28 EP disclosed
EP-2433936-A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof Purdue Pharma LP (US) 2012-03-28 EP disclosed
WO-2009027820-A2 SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA L.P. (DE) 2009-03-05 WO disclosed